STAMFORD, Conn., Nov. 07, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating AnaptysBio, Inc. (Nasdaq: ANAB) (“AnaptysBio” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether AnaptysBio’s board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of AnaptysBio stockholders to elect directors of their choosing.
AnaptysBio stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
- Media Advisory: See how made-in-British Columbia clean tech is creating jobs and reaching new markets in Europe and Asia - April 22, 2025
- From Trade-Ins to Top Picks: CarMax Reveals Used EV Shopping Trends - April 22, 2025
- Creatd, Inc. to Acquire Air Charter Advisors in $3-$6 Million Stock Deal, Further Strengthening Its Aviation Portfolio Following the $8.3 Million Flyte Acquisition - April 22, 2025
